MyFinsight
Home
Blog
About
Contact
Download
Download image
Sublocade
$794M
Sublingual And Other
$226M
Perseris
$24M
OPVEE
$8M
US
$1,053M
Non Us
$186M
Net revenue
$1,239M
Gross profit
$994M
Other operating
(income) expense, net
-$3M
Cost of sales
$246M
Operating income (loss)
$262M
Interest income
$22M
Selling, general and
administrative
$634M
Research and development
$97M
Litigation settlement
-$3M
Income (loss) before
income taxes
$239M
Interest expense
$45M
Net income (loss)
$210M
Income tax expense
(benefit)
$29M
Back
Back
Income Statement
source: myfinsight.com
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)